Feedback / Questions
Dasynoc (dasatinib amorphous) - Xspray Pharma
https://www.businesswire.com/news/home/20250812575897/en/Xspray-Pharma-Signs-License-Agreement-with-Handa-Therapeutics-to-Receive-up-to-Double-Digit-Royalty-on-Handas-Net-Proceeds
Aug 12, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next